Headquartered in Jordan, and with more than 30 years of experience in providing high quality pharmaceutical products, Dar Al Dawa is a leading regional generic pharmaceutical manufacturer, placed on the frontier of healthcare developers, and marketing its products in more than 30 countries around the world. The company developed a wide range of products, covering several major therapeutic categories including Cardiovascular, CNS, Anti-inflammatory, and Dermatological products. More than 85% of the company's production is geared towards exports, in the Middle East, Africa and some Eastern and Western European countries, like the UK, Germany, and France. Our state of the art facilities are located in Jordan, south west of the capital Amman, complying with the latest cGMP requirements, with many accreditations from regional and international health authorities, such asTGA (Australia), IMB (Ireland), and JFDA (Jordan). We have established several strategic alliances with several regional and multinational companies, including Novartis, Pfizer, Chanelle, and Mylan/Merck. We also produce several products in our partners' facilities in several countries like Algeria, Tunisia, Morocco, and France.